Wong L, Lee H, Alias H, Zimet G, Liu T, Lin Y
Hum Vaccin Immunother. 2024; 20(1):2313860.
PMID: 38359815
PMC: 10877984.
DOI: 10.1080/21645515.2024.2313860.
Vaghela G, Shukla A, Dave D, Lamichhane A
Health Sci Rep. 2024; 7(1):e1821.
PMID: 38250475
PMC: 10797158.
DOI: 10.1002/hsr2.1821.
Cooper D, Harmon D, Alemayehu C, Levy J, Gastanaduy M, Birdsall Fort L
West J Emerg Med. 2024; 24(6):1073-1084.
PMID: 38165190
PMC: 10754190.
DOI: 10.5811/westjem.57449.
Scala A, Cavallo P
PLoS One. 2023; 18(9):e0290652.
PMID: 37708163
PMC: 10501570.
DOI: 10.1371/journal.pone.0290652.
Welch E, Johnson T, Chen T, Ma J, Islam S, Michalegko L
Vaccines (Basel). 2023; 11(7).
PMID: 37515024
PMC: 10385302.
DOI: 10.3390/vaccines11071208.
COVID-19 vaccination and race - A nationwide survey of vaccination status, intentions, and trust in the US general population.
Brown C, Morlock A, Blakolmer K, Heidari E, Morlock R
J Manag Care Spec Pharm. 2022; 28(12):1429-1438.
PMID: 36427337
PMC: 10372999.
DOI: 10.18553/jmcp.2022.28.12.1429.
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?.
Siani A, Tranter A
Vaccine. 2022; 40(50):7262-7269.
PMID: 36333226
PMC: 9618445.
DOI: 10.1016/j.vaccine.2022.10.061.
Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
Agosti F, Toffolutti V, Cavalli N, Nivakoski S, Mascherini M, Aassve A
PLoS One. 2022; 17(9):e0273555.
PMID: 36129897
PMC: 9491558.
DOI: 10.1371/journal.pone.0273555.
Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols.
Elekhnawy E, Negm W, El-Sherbeni S, Zayed A
Inflammopharmacology. 2022; 30(6):1935-1954.
PMID: 36018432
PMC: 9411846.
DOI: 10.1007/s10787-022-01050-7.
Exploring the Willingness of the COVID-19 Vaccine Booster Shots in China Using the Health Belief Model: Web-Based Online Cross-Sectional Study.
Hu D, Liu Z, Gong L, Kong Y, Liu H, Wei C
Vaccines (Basel). 2022; 10(8).
PMID: 36016224
PMC: 9416363.
DOI: 10.3390/vaccines10081336.
Predicting death risk analysis in fully vaccinated people using novel extreme regression-voting classifier.
Saad E, Sadiq S, Jamil R, Rustam F, Mehmood A, Choi G
Digit Health. 2022; 8:20552076221109530.
PMID: 35898288
PMC: 9309760.
DOI: 10.1177/20552076221109530.
Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
Saad E, Sadiq S, Jamil R, Rustam F, Mehmood A, Choi G
PLoS One. 2022; 17(6):e0270327.
PMID: 35767542
PMC: 9242465.
DOI: 10.1371/journal.pone.0270327.
Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
Mundagowa P, Tozivepi S, Chiyaka E, Mukora-Mutseyekwa F, Makurumidze R
PLoS One. 2022; 17(4):e0266724.
PMID: 35446850
PMC: 9022878.
DOI: 10.1371/journal.pone.0266724.
The relationship between macro-socioeconomics determinants and COVID-19 vaccine distribution.
Roghani A
AIMS Public Health. 2021; 8(4):655-664.
PMID: 34786426
PMC: 8568597.
DOI: 10.3934/publichealth.2021052.
Mathematical analysis for the effect of voluntary vaccination on the propagation of Corona virus pandemic.
Ahmad W, Abbas M, Rafiq M, Baleanu D
Results Phys. 2021; 31:104917.
PMID: 34722138
PMC: 8536489.
DOI: 10.1016/j.rinp.2021.104917.
Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine.
Ou M, Boyarsky B, Zeiser L, Chiang T, Ruddy J, Van Pilsum Rasmussen S
Transplant Direct. 2021; 7(7):e713.
PMID: 34131585
PMC: 8196090.
DOI: 10.1097/TXD.0000000000001171.
COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation.
Sheikh A, Pal S, Javed N, Shekhar R
Infect Dis Rep. 2021; 13(2):429-436.
PMID: 34069242
PMC: 8162348.
DOI: 10.3390/idr13020041.
COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey.
Hagens A, Inkaya A, Yildirak K, Sancar M, van der Schans J, Acar Sancar A
Vaccines (Basel). 2021; 9(4).
PMID: 33919586
PMC: 8073609.
DOI: 10.3390/vaccines9040399.
Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake.
Nguyen L, Joshi A, Drew D, Merino J, Ma W, Lo C
medRxiv. 2021; .
PMID: 33655271
PMC: 7924296.
DOI: 10.1101/2021.02.25.21252402.
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y
Lancet. 2021; 397(10278):1023-1034.
PMID: 33587887
PMC: 7906643.
DOI: 10.1016/S0140-6736(21)00306-8.
